Skip to main content

The current state of antiplatelet therapy in acute coronary syndromes: the data and the real world.

Publication ,  Journal Article
Alexander, JH
Published in: Cleve Clin J Med
April 2009

Managing antiplatelet therapy for patients with acute coronary syndromes (ACS) is complex, and current therapy options and approaches for these patients are suboptimal. Despite the use of available antiplatelet therapies--aspirin, clopidogrel, and the parenteral glycoprotein IIb/IIIa inhibitors--recurrence of ischemic events in patients with ACS continues to rise over time. Moreover, bleeding remains an important--and often underappreciated--risk with these therapies, and national registries demonstrate that dosing of antiplatelet therapies frequently strays from evidence-based guidelines. Recent quality-improvement initiatives developed in conjunction with national registries of patients with ACS promise to improve adherence to guidelines through hospital-specific performance reports. More evidence-based use of existing and emerging antiplatelet agents has the potential to improve both ischemic and bleeding outcomes in patients with ACS.

Duke Scholars

Published In

Cleve Clin J Med

DOI

EISSN

1939-2869

Publication Date

April 2009

Volume

76 Suppl 1

Start / End Page

S16 / S23

Location

United States

Related Subject Headings

  • Platelet Aggregation Inhibitors
  • Humans
  • General & Internal Medicine
  • Acute Coronary Syndrome
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Alexander, J. H. (2009). The current state of antiplatelet therapy in acute coronary syndromes: the data and the real world. Cleve Clin J Med, 76 Suppl 1, S16–S23. https://doi.org/10.3949/ccjm.76.s1.03
Alexander, John H. “The current state of antiplatelet therapy in acute coronary syndromes: the data and the real world.Cleve Clin J Med 76 Suppl 1 (April 2009): S16–23. https://doi.org/10.3949/ccjm.76.s1.03.
Alexander, John H. “The current state of antiplatelet therapy in acute coronary syndromes: the data and the real world.Cleve Clin J Med, vol. 76 Suppl 1, Apr. 2009, pp. S16–23. Pubmed, doi:10.3949/ccjm.76.s1.03.

Published In

Cleve Clin J Med

DOI

EISSN

1939-2869

Publication Date

April 2009

Volume

76 Suppl 1

Start / End Page

S16 / S23

Location

United States

Related Subject Headings

  • Platelet Aggregation Inhibitors
  • Humans
  • General & Internal Medicine
  • Acute Coronary Syndrome
  • 32 Biomedical and clinical sciences